News Releases

News and information from The Leukemia & Lymphoma Society

Narrow Networks and High Cost-Sharing Among Concerns Raised by New Report on Affordable Care Act

Contact: Andrea Greif (914) 821-8958
andrea.greif@lls.org White Plains, NY (Jan. 15, 2014) - Many qualified health plans participating in the new insurance exchanges have limited access to National Cancer Institute (NCI) designated cancer or transplant centers, and would impose high out-of-pocket costs for patients purchasing at the silver and bronze levels, according to a report commissioned by The Leukemi...

News - Eastern Pennsylvania

Read news releases about important blood cancer and health news and past and current news and events from The Leukemia & Lymphoma Society's Eastern Pennsylvania Chapter.  

Newsletter-Iowa

Please our enjoy the Iowa Chapter Newsletters as we hope to keep you connected and up-to-date with the lastest information and news.  July 2017 Issue August 2017 Issue September 2017 Issue October 2017 Issue November 2017 Issue December 2017 Issue January 2018 Issue February 2018 Issue March 2018 Issue April 2018 Issue May 2018 Issue June 2018 Issue

To be added ...

The Leukemia & Lymphoma Society Announces Recipients of Screen to Lead Grant Program

Contact: Andrea Greif
andrea.greif@lls.org
(914) 821-8958
  White Plains, NY (January 16, 2014) - The Leukemia & Lymphoma Society (LLS) today is pleased to announce the researchers who will receive funding through The Screen to Lead program - a new grant program to support drug discovery specifically directed toward medicinal chemistry and/or drug target screening in blood cancers. LL...

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma

For Immediate Release
Contact: Andrea Greif
914-821-8958
andrea.greif@lls.org

(White Plains, NY) - November 13, 2013 - Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with mantle cell lymphoma (MCL) is a significant advance for patients with this blood cancer.

It was approved as a single agent for treatment of patients with MCL...

Cancer Research Funded by The Leukemia & Lymphoma Society Featured in New PBS Documentary Series


To view the entire multi-media release, click here. Contact: Marcie Klein
(914) 821-8205
marcie.klein@lls.org White Plains, NY (February 23, 2015) - Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE E...

New Partnership Launches to Empower People Diagnosed with Lymphoma

For Immediate Release
Contact: Andrea Greif
 Phone: (914) 821-8958
Email:  andrea.greif@lls.org White Plains, NY (Feb. 10, 2015) - The Leukemia & Lymphoma Society (LLS) together with the Lymphoma Research Foundation (LRF), CancerCare, the Association of Community Cancer Centers (ACCC) and Genentech announced the launch of a new partnership, the Alliance for Resource Collaboration...

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org (White Plains, NY) - January 29, 2015  - Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib (Imbruvica ®) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare ...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: